Sir Richard Sykes serves as Chairman of The Royal Institution of Great Britain, Chairman of King Edward VII’s Hospital, Chairman for Omnicyte Ltd and as a Non-Executive Director of PDS Biotechnology Corp. Sir Richard is also Chairman of The UK Stem Cell Foundation and on the International Advisory Board, of A*Star Biomedical Research Council, Singapore and Chancellor of Brunel University.
Sir Richard has previously held a number of senior appointments including Chairman and Chief Executive of Glaxo and Chairman and Chief Executive Glaxo Wellcome plc following the acquisition of Wellcome. He led the company through the formation of GlaxoSmithKline plc, where he was Chairman and CEO.
Sir Richard has also been Chairman of NetScientific plc, the Imperial College Healthcare NHS Trust, PDS Operating Corp, British Pharma Group, Frontier Smart Technology Group ltd, Medeus Pharma Limited, Vice Chairman at Swiss life sciences company Lonza Group AG, Deputy Chairman Eurasian Natural Resources Corp, a member of the President’s Committee of the Confederation of British Industry, a member of the UK Trade Policy Forum, Chairman of the Task Force for Inward Investment in the UK Pharmaceutical Industry, a member of the Advisory Committee for Human Genome Research, a member of the Council for Industry & Higher Education and member of DTI’s Strategy Board. He was also a Senior Independent Director of Rio Tinto plc, on the board of ContraFect Corp and a Non-Executive Chairman of Circassia Holdings Ltd.
Pascal Colombani previously chaired the Supervisory Board of Areva, was Chairman of Valeo SA and was Chairman and Chief Executive Officer of the French Atomic Energy Commission. Pascal is President of TII Strategies SASU, a consulting and investment company, since 2014. He also serves as a member of the EMEA advisory board of JPMorgan Chase, as Senior Advisor of Kearney, a global management consulting firm, as a Senior Advisor of Truffle Capital, and as the Lead Director at TechnipFMC plc.
Chad Holliday is Chairman of Royal Dutch Shell and serves as the Lead Independent Director at Deere & Company and Hospital Corporation of America (HCA). He previously served as CEO and then Chairman of Dupont, Chairman of the Bank of America Corporation, The Business Council, Catalyst, the National Academy of Engineering, the Society of Chemical Industry (American Section) and the World Business Council for Sustainable Development.
Peter Livanos is Chairman of Gaslog Ltd, Ceres Hellenic Shipping Enterprises Ltd, EnergyLog Ltd, DryLog Ltd and TankLog Ltd. He is a Director of MW&L and holds directorships and memberships in various international companies and committees. He is a member of the Council of the American Bureau of Shipping and chairman of the Greek National Committee. Peter is also a member of the Board of Trustees for New York-Presbyterian Hospital.